HR 6868
ACCESS Through OTC Innovation Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 13, 2026, 4:11 PM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the ACCESS Through OTC Innovation Act, aims to streamline the process by which the Food and Drug Administration (FDA) reviews requests for over-the-counter (OTC) medications. Specifically, it directs the FDA to use the least burdensome method possible when evaluating requests to determine if a drug is generally recognized as safe and effective. The bill also outlines procedures for the FDA to work with requesters, including offering recommendations on needed evidence and documenting meeting discussions as part of the official record.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.